This HTML5 document contains 67 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n14http://linked.opendata.cz/resource/mesh/concept/
n20http://linked.opendata.cz/resource/drugbank/drug/DB04630/identifier/chemspider/
n8http://linked.opendata.cz/resource/drugbank/drug/DB04630/identifier/chebi/
n17http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n19http://linked.opendata.cz/resource/drugbank/drug/DB04630/identifier/wikipedia/
n6http://linked.opendata.cz/resource/drugbank/drug/DB04630/identifier/pharmgkb/
n16http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n11http://linked.opendata.cz/resource/drugbank/drug/DB04630/identifier/kegg-compound/
n12http://linked.opendata.cz/resource/drugbank/drug/DB04630/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://linked.opendata.cz/resource/drugbank/drug/DB04630/identifier/pubchem-compound/
n13http://linked.opendata.cz/ontology/mesh/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n7http://linked.opendata.cz/resource/drugbank/property/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04630/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n5http://linked.opendata.cz/resource/drugbank/drug/DB04630/identifier/drugbank/

Statements

Subject Item
n2:DB04630
rdf:type
n3:Drug
n3:description
A hormone secreted by the adrenal cortex that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium. [PubChem]
n3:generalReferences
# Williams JS, Williams GH: 50th anniversary of aldosterone. J Clin Endocrinol Metab. 2003 Jun;88(6):2364-72. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/12788829
n3:group
experimental
owl:sameAs
n16:DB04630 n17:DB04630
dcterms:title
Aldosterone
adms:identifier
n5:DB04630 n6:PA164924487 n8:27584 n9:5839 n10:46505770 n11:C01780 n12:AS4 n19:Aldosterone n20:5633
n3:synonym
18-Formyl-11beta,21-dihydroxy-4-pregnene-3,20-dione Aldosteronum 18-Oxocorticosterone 11beta,21-Dihydroxy-3,20-diketopregn-4-ene-18-al 11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al Elektrocortin Aldosterona 11beta,21-Dihydroxy-3,20-diketo-4-pregnen-18-al (+)-aldosterone 11beta,21-dihydroxy-3,20-dioxo-pregn-4-ene-18-al D-aldosterone Electrocortin 18-Aldocorticosterone Aldocortin 11beta,21-dihydroxy-3,20-dioxo-4-pregnen-18-al Aldocortene 11beta,21-Dihydroxypregn-4-ene-3,18,20-trione Aldocorten
n3:synthesisReference
Jack Fishman, Elliot Hahn, Gregory A. Smith, "Aldosterone biosynthesis inhibitor." U.S. Patent US5120724, issued December, 1969.
n13:hasConcept
n14:M0000686
n3:IUPAC-Name
n7:271B44CD-363D-11E5-9242-09173F13E4C5
n3:InChI
n7:271B44D3-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n7:271B44D2-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n7:271B44CF-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n7:271B44D0-363D-11E5-9242-09173F13E4C5
n3:SMILES
n7:271B44D1-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n7:271B44CB-363D-11E5-9242-09173F13E4C5 n7:271B44E3-363D-11E5-9242-09173F13E4C5
n3:logP
n7:271B44CC-363D-11E5-9242-09173F13E4C5 n7:271B44C9-363D-11E5-9242-09173F13E4C5 n7:271B44E5-363D-11E5-9242-09173F13E4C5
n3:logS
n7:271B44CA-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n7:271B44D9-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n7:271B44DA-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n7:271B44D4-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n7:271B44D5-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n7:271B44D7-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n7:271B44D6-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n7:271B44D8-363D-11E5-9242-09173F13E4C5
n3:affectedOrganism
Humans and other mammals
n3:casRegistryNumber
52-39-1
n3:Bioavailability
n7:271B44DF-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n7:271B44E1-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n7:271B44E2-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n7:271B44E4-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n7:271B44DE-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n7:271B44DD-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n7:271B44E0-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n7:271B44CE-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n7:271B44DB-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n7:271B44DC-363D-11E5-9242-09173F13E4C5